On Psychedelics: Promising Benefits and Significant Risks

In our first episode, we speak with Richard A. Friedman, M.D. about the latest news exploring the intersection of psychedelics and psychiatry. Dr. Friedman highlights the effects psychedelic drugs have on the brain’s neuroplasticity, misconceptions about mind altering drugs, and the surprising findings of research on the drugs’ mental health benefits and risks.

Please note that the use of psychedelics is not FDA approved and is only to be used by in medical research settings under strict safety protocols.

Read Dr. Friedman’s article referenced in this episode 

Featured Speaker: Richard A. Friedman, M.D. is a professor of clinical psychiatry and director of the Psychopharmacology Clinic at Weill Cornell Medicine. His clinical and research focus is on anxiety, mood disorders, psychopharmacology, and refractory depression.

Learn more about Dr. Friedman